Leerink Comments On Orexigen Therapeutics, Says Current Projections Could Prove To Be 'Conservative'
March 04, 2015 at 12:01 PM EST
In a report published Wednesday, Leerink analyst Paul Matteis commented on Orexigen Therapeutics, Inc. (NASDAQ: OREX) and wrote that ...